Sign up
Quantellect · Congress · Trade Detail
IPHIInphi Corporation (IPHI) [ST] F ILINg S TATUS : New S UbHOLDINg O F : Merrill Lynch- Advisor Discretion Account
DemocratHouse

Thomas R. Suozzi bought Inphi Corporation (IPHI) [ST] F ILINg S TATUS : New S UbHOLDINg O F : Merrill Lynch- Advisor Discretion Account (IPHI)

Thomas R. Suozzi (D-NY), a U.S. Representative, has disclosed 2 trades in Inphi Corporation (IPHI) [ST] F ILINg S TATUS : New S UbHOLDINg O F : Merrill Lynch- Advisor Discretion Account (IPHI) since 2020, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Thomas R. Suozzi bought $1,001 - $15,000 of Inphi Corporation (IPHI) [ST] F ILINg S TATUS : New S UbHOLDINg O F : Merrill Lynch- Advisor Discretion Account (IPHI) on April 29, 2020. Since that trade, IPHI is up +0.00% against the S&P 500 up +175.19%, an outperformance of -175.19%.

Across these filings, Thomas R. Suozzi has been a balanced trader of IPHI (a buy-to-sell ratio of 1.00). The most recent disclosed IPHI transaction shown was dated November 19, 2020. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

IPHI trades
2
Disclosed Vol
$16K
Buys
1
50%
Sells
1
50%
Buy / Sell
1.00
ratio
First → Last
2020

Thomas R. Suozzi's IPHI trades vs the price

IPHI is up +0.00% since Thomas R. Suozzi bought on April 29, 2020, versus +175.19% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+175.19%
Outperformance vs S&P 500
-175.19%

All Thomas R. Suozzi IPHI trades

TradedTypeSizeReturnEst. profit
November 19, 2020SELL$1,001 - $15,000N/A
April 29, 2020BUY$1,001 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Thomas R. Suozzi & IPHI trading FAQ

Is it legal for Thomas R. Suozzi to trade Inphi Corporation (IPHI) [ST] F ILINg S TATUS : New S UbHOLDINg O F : Merrill Lynch- Advisor Discretion Account (IPHI) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Inphi Corporation (IPHI) [ST] F ILINg S TATUS : New S UbHOLDINg O F : Merrill Lynch- Advisor Discretion Account (IPHI), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Thomas R. Suozzi buy IPHI?

Thomas R. Suozzi disclosed a purchase of $1,001 - $15,000 of Inphi Corporation (IPHI) [ST] F ILINg S TATUS : New S UbHOLDINg O F : Merrill Lynch- Advisor Discretion Account (IPHI) on April 29, 2020, according to public STOCK Act filings.

How has IPHI performed since Thomas R. Suozzi's trade?

Since Thomas R. Suozzi bought IPHI on April 29, 2020, the stock is up +0.00%, versus +175.19% for the S&P 500 over the same period, an outperformance of -175.19%.

How many times has Thomas R. Suozzi traded IPHI?

Thomas R. Suozzi has disclosed 2 IPHI trades since 2020 (1 purchase and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional IPHI trades?

Quantellect tracks every disclosed congressional trade in Inphi Corporation (IPHI) [ST] F ILINg S TATUS : New S UbHOLDINg O F : Merrill Lynch- Advisor Discretion Account (IPHI) on the Inphi Corporation (IPHI) [ST] F ILINg S TATUS : New S UbHOLDINg O F : Merrill Lynch- Advisor Discretion Account congressional trading page, which aggregates filings across all members of Congress.

Thomas R. Suozzi's IPHI tradesAll congressional filings for Inphi Corporation (IPHI) [ST] F ILINg S TATUS : New S UbHOLDINg O F : Merrill Lynch- Advisor Discretion AccountThomas R. Suozzi's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.